search again

Revefenacin (Yupelri) Inhalation Solution

Nationwide rates for HCPCS J7677

Revefenacin inhalation solution, FDA-approved final product, noncompounded, administered through DME, 1 mcg

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$10%20%40%10th90th$0Professionalmedian $0 · 10th–90th $0$00%50%10th90th$0$0.0$0.2$2.0$20.0$200.0$2.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.20
Median
$0.32
Typical High
$0.56
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.20
Median
$0.20
Typical High
$0.26
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.21
Median
$0.25
Typical High
$0.55
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.20
Median
$0.20
Typical High
$0.27
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.21
Median
$0.32
Typical High
$0.62
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.19
Median
$0.20
Typical High
$0.31
United
Setting
Facility
Modifier
Global
Typical Low
$0.08
Median
$0.20
Typical High
$0.36
United
Setting
Professional
Modifier
Global
Typical Low
$0.08
Median
$0.20
Typical High
$0.26